Port Site Pain Following Percutaneous Externally-Assembled Laparoscopic Donor Nephrectomy
Stopped early · Not applicable
Conditions studied: Laparoscopic Donor Nephrectomy
In brief
A single-arm prospective internally-controlled study. Patients will undergo Percutaneous Externally-Assembled Laparoscopic (PEAL) donor nephrectomy where one or more 3 mm instruments are added or substituted for conventional 5 or 12 mm trocars. Multiple outcome measures (endpoints) will be measured including time to first opioid use, total inpatient opioid dosage, patient ranking of painfulness of each port site, duration of ileus, time to ambulation, length of hospital stay, presence of any intraoperative or postoperative complications, operating time, estimated blood loss, and other routine parameters collected in a prospective surgical study
Key facts
- Study ID
- NCT02805517
- Run by
- Loma Linda University
- People needed
- 6
- Starts
- 2016-07-11
- Expected to finish
- 2021-05-26
- Last updated by the study team
- 2022-12-13
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients undergoing laparoscopic donor nephrectomy
You may not qualify if…
- Patients unwilling to participate in the study
- Patients unfit for laparoscopic surgery
Where it is running
- Loma Linda Medical Center — Loma Linda, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.